A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin
PHASE2CompletedINTERVENTIONAL
Enrollment
113
Participants
Timeline
Start Date
February 29, 2004
Study Completion Date
October 31, 2004
Conditions
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Interventions
DRUG
topiramate
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00231647 - A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin | Biotech Hunter | Biotech Hunter